Tasocitinib Reduces Symptoms of Rheumatoid Arthritis

Links shared publicly online about this topic

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 12:41 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/dbhtqB

2 years ago...

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

twurl.nl — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at twurl.nl

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 11:36 am By:

Stroke_News News-Medical.Net Health News

Stroke News: ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member ... http://twurl.nl/6p6ovr

2 years ago...

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis

news-medical.net — “Genentech, Inc., a member of the Roche Group today announced updated data from a Phase III study (ROSE) that showed rheumatoid arthritis (RA) patients receiving ACTEMRA (tocilizumab) experienced a rapid, measured response as early as one week after beginning ACTEMRA, and improvement in disease activity within four weeks.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 8, 2010 at 7:28 am By:

NewsMedical News-Medical.Net Health News

ACTEMRA reduces signs, symptoms in patients with rheumatoid arthritis: Genentech, Inc., a member of the Roche Gr... http://bit.ly/a270wI

2 years ago...

In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function - Health News - redOrbit

redorbit.com — “NEW YORK, Nov. 7, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc.View full resource at redorbit.com

  • View Related
  • Share

Most Recently Shared on November 7, 2010 at 11:23 pm By:

OralHealth_OW Oral Health OW OW Health

In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Si... http://bit.ly/bHHxot

2 years ago...

In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function - Nov 7, 2010

pfizer.mediaroom.com — “In First Phase 3 Trial, Tasocitinib (CP-690,550), an Oral JAK Inhibitor, Administered as Monotherapy, Reduces Signs and Symptoms of Active Rheumatoid Arthritis and Improves Physical Function - Nov 7, 2010View full resource at pfizer.mediaroom.com

  • View Related
  • Share

Most Recently Shared on November 7, 2010 at 10:08 pm By:

pfizer_news Pfizer Inc. Pharma

Press Release: In First Phase 3 Trial...http://bit.ly/c9aVVz

2 years ago...

Rheumatoid Arthritis Symptoms, Causes, Treatment - How is rheumatoid arthritis treated on MedicineNet

medicinenet.com — “Learn more about rheumatoid arthritis, an autoimmune disease that causes chronic joint inflammation, which has symptoms that include stiffness, fever, muscle and joint aches, loss of appetite, and fatigue. Treatment of rheumatoid arthritis incorporates the use of first-line drugs (aspirin and corticosteroids for pain and inflammation) and second-line drugs (methotrexate and hydroxychloroquine to prevent joint destruction and promote remission).View full resource at medicinenet.com

  • View Related
  • Share

Most Recently Shared on August 2, 2010 at 10:54 pm By:

HealthTrendster HealthTrendster Health Executive

Treament goals in RA : Limit joint inflammation & pain, boost joint function, & prevent joint destruction & deformity. http://bit.ly/cZp2M7

2 years ago...

Healthcare Professionals - Rheumatoid Arthritis

remicade.com — “Learn about rheumatoid arthritis and how REMICADE" (infliximab) is indicated for inhibiting joint damage in patients with moderate to severe rheumatoid arthritis.View full resource at remicade.com

  • View Related
  • Share

Most Recently Shared on April 25, 2010 at 5:42 pm By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

Understanding the pathophysiology of rheumatoid arthritis. Info for health professionals from Remicade. http://bit.ly/9F0A90

2 years ago...

Reducing Symptoms of Rheumatoid Arthritis - icyou health videos

icyou.com — “While there's no cure for RA, new treatments offer patients the opportunity for an improved quality of life, including the possibility of re...View full resource at icyou.com

  • View Related
  • Share

Most Recently Shared on July 6, 2010 at 10:00 pm By:

icyou Tori Joseph - icyou.com Health Site

While there's no cure 4 Rheumatoid Arthritis, new treatments offer an improved quality of life & possibility of remission http://ow.ly/27MLt

2 years ago...

Rheumatoid Arthritis and REMICADE (infliximab) Treatment

remicade.com — “REMICADE" (infliximab) has been proven to reduce rheumatoid arthritis symptoms and is the only FDA-approved rheumatoid arthritis treatment to block TNF-alpha.View full resource at remicade.com

  • View Related
  • Share

Most Recently Shared on April 23, 2010 at 3:37 am By:

SusanS_Health Susan Scroggins Active Health Library and Health Advocate

It's possible to change the course of your rheumatoid arthritis with the use of Remicade.Learn more about Remicade & RA.http://bit.ly/bqM4TG

2 years ago...

Vertex rheumatoid arthritis drug meets study goals | Reuters

reuters.com — “NEW YORK (Reuters) - Vertex Pharmaceuticals Inc said its experimental oral drug for rheumatoid arthritis met the main goals of a mid-stage study.Vertex's VX-509 significantly reduced signs and symptomsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 9:16 pm By:

Reuters_Health Reuters Health Health News

Vertex rheumatoid arthritis drug meets study goals http://t.co/PZXhHgY

9 months ago...

Vertex rheumatoid arthritis drug meets study goals | Reuters

reuters.com — “NEW YORK (Reuters) - Vertex Pharmaceuticals Inc said its experimental oral drug for rheumatoid arthritis met the main goals of a mid-stage study.Vertex's VX-509 significantly reduced signs and symptomsView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 6, 2011 at 9:15 pm By:

Bradmed Brad Lipson, DO Doctor, Family Medicine Doctor, Physician, and Active Health Library

Vertex rheumatoid arthritis drug meets study goals: NEW YORK (Reuters) - Vertex Pharmaceuticals Inc said i... http://t.co/AkMuo3O

9 months ago...

Scientists reveal that homeopathic consultations can reduce symptoms of rheumatoid arthritis

news-medical.net — “New evidence that homeopathic consultations can reduce the symptoms of rheumatoid arthritis has been revealed by scientists from the University of Southampton.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 16, 2010 at 8:15 am By:

RA_Wisdom OrganizedWisdom RA OW Health

Scientists reveal that homeopathic consultations can reduce symptoms of rheumatoid arthritis: New evidence that ... http://bit.ly/ajVvwp

2 years ago...

Pfizer drug meets rheumatoid arthritis study goals | The Associated Press | News | Washington Examiner

washingtonexaminer.com — “Drug developer Pfizer Inc. said Friday its potential rheumatoid arthritis drug met its key treatment goals in a late-stage study. The company said the drug tofacitinib, formerly called tasocitinib, met its key goals of reducing signs and symptoms of the condition in a six-month period. Rheumatoid arthritis is a chronic inflammatory disease typically affecting joints.View full resource at washingtonexaminer.com

  • View Related
  • Share

Most Recently Shared on March 4, 2011 at 4:39 pm By:

RA_Wisdom OrganizedWisdom RA OW Health

Pfizer drug meets rheumatoid arthritis study goals: The Associated Press The Associated Press NEW YORK Drug deve... http://bit.ly/dKi8LI

1 year ago...

Reduce Stress to Reduce Your Rheumatoid Arthritis Symptoms - Addressing Both the Physical and Emotional Sides of Pain is Your Best Defense Against RA

spineuniverse.com — “Stress will exacerbate rheumatoid arthritis pain, so you need to know how to control it. Stress management is important to both your emotional and physical health. This article includes ways to reduce your stress, and in turn, reduce your symptoms.View full resource at spineuniverse.com

  • View Related
  • Share

Most Recently Shared on October 21, 2009 at 2:18 pm By:

SpineUniverse SpineUniverse Health Site

If you have rheumatoid arthritis, don't ignore the emotional side of your pain. Learn about the impact of stress on RA: http://bit.ly/nMVlu

3 years ago...

Reduce Stress to Reduce Your Rheumatoid Arthritis Symptoms - Addressing Both the Physical and Emotional Sides of Pain is Your Best Defense Against RA

spineuniverse.com — “Stress will exacerbate rheumatoid arthritis pain, so you need to know how to control it. Stress management is important to both your emotional and physical health. This article includes ways to reduce your stress, and in turn, reduce your symptoms.View full resource at spineuniverse.com

  • View Related
  • Share

Most Recently Shared on May 20, 2011 at 8:43 pm By:

SpineUniverse SpineUniverse Health Site

Reduce Stress to Reduce Your Rheumatoid Arthritis Symptoms http://dlvr.it/SQ4q9

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390